131 related articles for article (PubMed ID: 8100040)
1. P-glycoprotein-mediated renal tubular secretion of digoxin: the toxicological significance of the urine-blood barrier model.
Ito S; Woodland C; Harper PA; Koren G
Life Sci; 1993; 53(2):PL25-31. PubMed ID: 8100040
[TBL] [Abstract][Full Text] [Related]
2. Energy-dependent transport of digoxin across renal tubular cell monolayers (LLC-PK1).
Ito S; Koren G; Harper PA; Silverman M
Can J Physiol Pharmacol; 1993 Jan; 71(1):40-7. PubMed ID: 8099844
[TBL] [Abstract][Full Text] [Related]
3. The mechanism of the verapamil-digoxin interaction in renal tubular cells (LLC-PK1).
Ito S; Woodland C; Harper PA; Koren G
Life Sci; 1993; 53(24):PL399-403. PubMed ID: 8246676
[TBL] [Abstract][Full Text] [Related]
4. Digoxin-cyclosporin A interaction: modulation of the multidrug transporter P-glycoprotein in the kidney.
Okamura N; Hirai M; Tanigawara Y; Tanaka K; Yasuhara M; Ueda K; Komano T; Hori R
J Pharmacol Exp Ther; 1993 Sep; 266(3):1614-9. PubMed ID: 8103797
[TBL] [Abstract][Full Text] [Related]
5. Transport of digoxin by human P-glycoprotein expressed in a porcine kidney epithelial cell line (LLC-PK1).
Tanigawara Y; Okamura N; Hirai M; Yasuhara M; Ueda K; Kioka N; Komano T; Hori R
J Pharmacol Exp Ther; 1992 Nov; 263(2):840-5. PubMed ID: 1359120
[TBL] [Abstract][Full Text] [Related]
6. Role of P-glycoprotein in renal tubular secretion of digoxin in the isolated perfused rat kidney.
Hori R; Okamura N; Aiba T; Tanigawara Y
J Pharmacol Exp Ther; 1993 Sep; 266(3):1620-5. PubMed ID: 8103798
[TBL] [Abstract][Full Text] [Related]
7. A model for the prediction of digoxin-drug interactions at the renal tubular cell level.
Woodland C; Ito S; Koren G
Ther Drug Monit; 1998 Apr; 20(2):134-8. PubMed ID: 9558126
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the major metabolites of verapamil as substrates and inhibitors of P-glycoprotein.
Pauli-Magnus C; von Richter O; Burk O; Ziegler A; Mettang T; Eichelbaum M; Fromm MF
J Pharmacol Exp Ther; 2000 May; 293(2):376-82. PubMed ID: 10773005
[TBL] [Abstract][Full Text] [Related]
9. The multidrug-resistance-reverser verapamil interferes with cellular P-glycoprotein-mediated pumping of daunorubicin as a non-competing substrate.
Spoelstra EC; Westerhoff HV; Pinedo HM; Dekker H; Lankelma J
Eur J Biochem; 1994 Apr; 221(1):363-73. PubMed ID: 7909520
[TBL] [Abstract][Full Text] [Related]
10. The MDR1 gene product, P-glycoprotein, mediates the transport of the cardiac glycoside, digoxin.
de Lannoy IA; Silverman M
Biochem Biophys Res Commun; 1992 Nov; 189(1):551-7. PubMed ID: 1360207
[TBL] [Abstract][Full Text] [Related]
11. Handling of digoxin and ouabain by renal tubular cells (LLC-PK1).
Ito S; Koren G; Harper PA
J Pharmacol Exp Ther; 1992 Jul; 262(1):109-13. PubMed ID: 1320681
[TBL] [Abstract][Full Text] [Related]
12. Atorvastatin coadministration may increase digoxin concentrations by inhibition of intestinal P-glycoprotein-mediated secretion.
Boyd RA; Stern RH; Stewart BH; Wu X; Reyner EL; Zegarac EA; Randinitis EJ; Whitfield L
J Clin Pharmacol; 2000 Jan; 40(1):91-8. PubMed ID: 10631627
[TBL] [Abstract][Full Text] [Related]
13. Pluronic P85 enhances the delivery of digoxin to the brain: in vitro and in vivo studies.
Batrakova EV; Miller DW; Li S; Alakhov VY; Kabanov AV; Elmquist WF
J Pharmacol Exp Ther; 2001 Feb; 296(2):551-7. PubMed ID: 11160643
[TBL] [Abstract][Full Text] [Related]
14. Mediation of cimetidine secretion by P-glycoprotein and a novel H(+)-coupled mechanism in cultured renal epithelial monolayers of LLC-PK1 cells.
Dudley AJ; Brown CD
Br J Pharmacol; 1996 Mar; 117(6):1139-44. PubMed ID: 8882608
[TBL] [Abstract][Full Text] [Related]
15. Clinical pharmacokinetic significance of the renal tubular secretion of digoxin.
Koren G
Clin Pharmacokinet; 1987 Nov; 13(5):334-43. PubMed ID: 3319348
[TBL] [Abstract][Full Text] [Related]
16. Estradiol regulation of P-glycoprotein expression in mouse kidney and human tubular epithelial cells, implication for renal clearance of drugs.
Kanado Y; Tsurudome Y; Omata Y; Yasukochi S; Kusunose N; Akamine T; Matsunaga N; Koyanagi S; Ohdo S
Biochem Biophys Res Commun; 2019 Nov; 519(3):613-619. PubMed ID: 31540689
[TBL] [Abstract][Full Text] [Related]
17. Modulators of P-glycoprotein-associated multidrug resistance.
Beck WT
Cancer Treat Res; 1991; 57():151-70. PubMed ID: 1686715
[No Abstract] [Full Text] [Related]
18. Renal tubular cell handling of digoxin and ouabain--in vitro study using LLC-PK1 cell lines.
Ito S; Harper PA; Koren G
Toxicol Lett; 1990 Sep; 53(1-2):189-91. PubMed ID: 2219165
[No Abstract] [Full Text] [Related]
19. The digoxin-propafenone interaction: characterization of a mechanism using renal tubular cell monolayers.
Woodland C; Verjee Z; Giesbrecht E; Koren G; Ito S
J Pharmacol Exp Ther; 1997 Oct; 283(1):39-45. PubMed ID: 9336306
[TBL] [Abstract][Full Text] [Related]
20. MDR1-mediated interaction of digoxin with antiarrhythmic or antianginal drugs.
Kakumoto M; Takara K; Sakaeda T; Tanigawara Y; Kita T; Okumura K
Biol Pharm Bull; 2002 Dec; 25(12):1604-7. PubMed ID: 12499648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
